MaaT Pharma Management
Management criteria checks 2/4
MaaT Pharma's CEO is Herve Affagard, appointed in Dec 2014, has a tenure of 9.33 years. directly owns 1.72% of the company’s shares, worth €1.80M. The average tenure of the management team and the board of directors is 1.2 years and 3.9 years respectively.
Key information
Herve Affagard
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.3yrs |
| CEO ownership | 1.7% |
| Management average tenure | 1.2yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -€20m |
| Sep 30 2023 | n/a | n/a | -€17m |
| Jun 30 2023 | n/a | n/a | -€15m |
| Mar 31 2023 | n/a | n/a | -€14m |
| Dec 31 2022 | n/a | n/a | -€14m |
| Sep 30 2022 | n/a | n/a | -€13m |
| Jun 30 2022 | n/a | n/a | -€12m |
| Mar 31 2022 | n/a | n/a | -€11m |
| Dec 31 2021 | €271k | €271k | -€9m |
| Sep 30 2021 | n/a | n/a | -€8m |
| Jun 30 2021 | n/a | n/a | -€7m |
| Mar 31 2021 | n/a | n/a | -€6m |
| Dec 31 2020 | €831k | €233k | -€5m |
Compensation vs Market: Insufficient data to establish whether Herve's total compensation is reasonable compared to companies of similar size in the French market.
Compensation vs Earnings: Herve's compensation has been consistent with company performance over the past year.
CEO
Herve Affagard (48 yo)
9.3yrs
Tenure
€271,201
Compensation
Mr. Herve Affagard is Co-Founder at MaaT Pharma SA and is its CEO since December 3, 2014. He is Director at MaaT Pharma SA since 2014.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Co-Founder & Director | 9.3yrs | €271.20k | 1.72% € 1.8m | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Chief Financial Officer | 8.3yrs | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Chief Scientific Officer | 1.5yrs | no data | no data | |
| Head of Investor Relations | less than a year | no data | no data | |
| Head of Clinical Development | less than a year | no data | no data | |
| Chief Business Officer | less than a year | no data | no data |
1.2yrs
Average Tenure
Experienced Management: MAAT's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Co-Founder & Director | 10.3yrs | €271.20k | 1.72% € 1.8m | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 3.8yrs | €30.40k | no data | |
| Independent Chairman | less than a year | no data | no data | |
| Independent Non Executive Director | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.9yrs | no data | no data | |
| Chair of Scientific Advisory Board | 3.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.9yrs | no data | no data | |
| Non-Executive Chairman of the Board | 8.3yrs | no data | no data | |
| Independent Non Executive Director | 3.3yrs | €7.10k | no data | |
| Independent Director | less than a year | no data | no data |
3.9yrs
Average Tenure
59yo
Average Age
Experienced Board: MAAT's board of directors are considered experienced (3.9 years average tenure).